Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
BMJ Open
|
August 3, 2024
Easing the way to achieving target serum urate in people with gout: protocol for a non-inferiority randomised strategy trial using an allopurinol dosing model in Aotearoa/New Zealand (the Easy-Allo Study)
Lisa Stamp, Leanne Te Karu, Susan Reid, et al.
Clinical Pharmacokinetics
|
July 28, 2025
The Influence of Patient Factors on the Population Pharmacokinetics of Colchicine: Implications for Safe and Effective Dosing
Daniel F B Wright, Hailemichael Z Hishe, Nicola Dalbeth, et al.
British Journal of Clinical Pharmacology
|
February 16, 2020
The pharmacokinetics of metformin in patients receiving intermittent haemodialysis
Klarissa A Sinnappah, Isabelle H S Kuan, Tilenka R J Thynne, et al.
British Journal of Clinical Pharmacology
|
July 27, 2023
A framework for understanding sources of bias in medication adherence research
Klarissa A Sinnappah, Dyfrig A Hughes, Sophie L Stocker, et al.
British Journal of Clinical Pharmacology
|
February 21, 2024
Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosing
Marcel Schulz, Matthew J Coleshill, Richard O Day, et al.
European Journal of Clinical Pharmacology
|
March 12, 2013
The population pharmacokinetics of allopurinol and oxypurinol in patients with gout
Daniel F B Wright, Lisa K Stamp, Tony R Merriman, et al.
Journal of Nephrology
|
March 25, 2025
Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping review
Noha A Kamel, Michael A Stokes, Daniel F B Wright, et al.
Seminars in Arthritis and Rheumatism
|
June 14, 2014
Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout
Lisa K Stamp, Tony R Merriman, Murray L Barclay, et al.
Clinical Pharmacokinetics
|
December 13, 2016
A Population Pharmacokinetic Model for <sup>51</sup>Cr EDTA to Estimate Renal Function
Isabelle H S Kuan, Stephen B Duffull, Tracey L Putt, et al.
Clinical and Translational Science
|
November 18, 2022
The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics
Hailemichael Z Hishe, Sophie L Stocker, Lisa K Stamp, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
BMJ Open
|
August 3, 2024
Easing the way to achieving target serum urate in people with gout: protocol for a non-inferiority randomised strategy trial using an allopurinol dosing model in Aotearoa/New Zealand (the Easy-Allo Study)
Lisa Stamp, Leanne Te Karu, Susan Reid, et al.
Clinical Pharmacokinetics
|
July 28, 2025
The Influence of Patient Factors on the Population Pharmacokinetics of Colchicine: Implications for Safe and Effective Dosing
Daniel F B Wright, Hailemichael Z Hishe, Nicola Dalbeth, et al.
British Journal of Clinical Pharmacology
|
February 16, 2020
The pharmacokinetics of metformin in patients receiving intermittent haemodialysis
Klarissa A Sinnappah, Isabelle H S Kuan, Tilenka R J Thynne, et al.
British Journal of Clinical Pharmacology
|
July 27, 2023
A framework for understanding sources of bias in medication adherence research
Klarissa A Sinnappah, Dyfrig A Hughes, Sophie L Stocker, et al.
British Journal of Clinical Pharmacology
|
February 21, 2024
Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosing
Marcel Schulz, Matthew J Coleshill, Richard O Day, et al.
European Journal of Clinical Pharmacology
|
March 12, 2013
The population pharmacokinetics of allopurinol and oxypurinol in patients with gout
Daniel F B Wright, Lisa K Stamp, Tony R Merriman, et al.
Journal of Nephrology
|
March 25, 2025
Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping review
Noha A Kamel, Michael A Stokes, Daniel F B Wright, et al.
Seminars in Arthritis and Rheumatism
|
June 14, 2014
Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout
Lisa K Stamp, Tony R Merriman, Murray L Barclay, et al.
Clinical Pharmacokinetics
|
December 13, 2016
A Population Pharmacokinetic Model for <sup>51</sup>Cr EDTA to Estimate Renal Function
Isabelle H S Kuan, Stephen B Duffull, Tracey L Putt, et al.
Clinical and Translational Science
|
November 18, 2022
The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics
Hailemichael Z Hishe, Sophie L Stocker, Lisa K Stamp, et al.
Page
of 8